TCM
Teza Capital Management’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,551
| Closed | -$349K | – | 327 |
|
|
2025
Q1 | $349K | Buy |
+2,551
| New | +$349K | 0.16% | 218 |
|
|
2024
Q2 | – | Sell |
-1,654
| Closed | -$357K | – | 587 |
|
|
2024
Q1 | $357K | Buy |
+1,654
| New | +$357K | 0.05% | 405 |
|
|
2023
Q4 | – | Sell |
-10,664
| Closed | -$2.74M | – | 562 |
|
|
2023
Q3 | $2.74M | Buy |
10,664
+8,832
| +482% | +$2.27M | 0.45% | 52 |
|
|
2023
Q2 | $522K | Buy |
+1,832
| New | +$522K | 0.08% | 283 |
|
|
2023
Q1 | – | Sell |
-8,074
| Closed | -$2.24M | – | 515 |
|
|
2022
Q4 | $2.24M | Buy |
8,074
+3,908
| +94% | +$1.08M | 0.43% | 47 |
|
|
2022
Q3 | $1.11M | Buy |
+4,166
| New | +$1.11M | 0.23% | 120 |
|
|
2022
Q2 | – | Sell |
-5,817
| Closed | -$1.23M | – | 426 |
|
|
2022
Q1 | $1.23M | Buy |
+5,817
| New | +$1.23M | 0.46% | 50 |
|
|
2021
Q4 | – | Sell |
-2,495
| Closed | -$706K | – | 438 |
|
|
2021
Q3 | $706K | Sell |
2,495
-4,922
| -66% | -$1.39M | 0.34% | 86 |
|
|
2021
Q2 | $2.57M | Buy |
+7,417
| New | +$2.57M | 0.42% | 67 |
|
|
2021
Q1 | – | Sell |
-2,090
| Closed | -$512K | – | 469 |
|
|
2020
Q4 | $512K | Buy |
+2,090
| New | +$512K | 0.29% | 122 |
|
|
2020
Q3 | – | Sell |
-6,604
| Closed | -$1.77M | – | 387 |
|
|
2020
Q2 | $1.77M | Buy |
+6,604
| New | +$1.77M | 0.39% | 59 |
|
|
2020
Q1 | – | Sell |
-3,313
| Closed | -$983K | – | 160 |
|
|
2019
Q4 | $983K | Sell |
3,313
-1,329
| -29% | -$394K | 0.27% | 99 |
|
|
2019
Q3 | $1.08M | Buy |
+4,642
| New | +$1.08M | 0.28% | 115 |
|
|
2018
Q3 | – | Sell |
-3,468
| Closed | -$1.01M | – | 383 |
|
|
2018
Q2 | $1.01M | Sell |
3,468
-256
| -7% | -$74.3K | 0.15% | 237 |
|
|
2018
Q1 | $1.02M | Buy |
3,724
+819
| +28% | +$224K | 0.25% | 141 |
|
|
2017
Q4 | $925K | Buy |
+2,905
| New | +$925K | 0.56% | 29 |
|